Syntheses and structure-activity relationships of 5,6,7, 8-tetrahydro-5,5,8,8-tetramethyl-2-quinoxaline derivatives with retinoic acid receptor alpha agonistic activity

J Med Chem. 2000 Feb 10;43(3):409-19. doi: 10.1021/jm990063w.

Abstract

In the course of our studies on retinoic acid receptor (RAR) agonists, we have designed and synthesized a series of quinoxaline derivatives. One of them, 4-[5-(5,6,7,8-tetrahydro-5,5,8, 8-tetramethyl-2-quinoxalinyl)-1H-2-pyrrolyl]benzoic acid (3a), which possesses a 2,5-disubstituted pyrrole moiety, showed selectivity for the RARalpha receptor and exerted highly potent cell-differentiating activity on HL-60 cells.

MeSH terms

  • Benzoates / chemical synthesis*
  • Benzoates / chemistry
  • Benzoates / metabolism
  • Benzoates / pharmacology
  • Binding, Competitive
  • Cell Differentiation / drug effects
  • Cell Line
  • Humans
  • Quinoxalines / chemical synthesis*
  • Quinoxalines / chemistry
  • Quinoxalines / metabolism
  • Quinoxalines / pharmacology
  • Receptors, Retinoic Acid / agonists*
  • Receptors, Retinoic Acid / metabolism
  • Retinoic Acid Receptor alpha
  • Retinoids / chemical synthesis*
  • Retinoids / chemistry
  • Retinoids / metabolism
  • Retinoids / pharmacology
  • Structure-Activity Relationship

Substances

  • Benzoates
  • Quinoxalines
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • Retinoids
  • ER 34617